Generalized exfoliative skin rash as an early predictor of supratherapeutic voriconazole trough levels in a leukemic child: A case report

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 42

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CUMM-6-3_013

تاریخ نمایه سازی: 9 آذر 1402

Abstract:

Background and Purpose: Skin rashes, mostly seen in children and adolescents, are considered among the most common side effects of azole antifungals. Although therapeutic concentrations of voriconazole (VCZ) have been documented for infected skin, there is no evidence specifying whether specific dermatologic side effects could predict high VCZ serum concentration, especially in high-risk leukemic children. Case report: Herein, we report a unique skin side effect of VCZ in a ۵-year-old boy with T-cell acute lymphoblastic leukemia (ALL) referred to Amir Medical Oncology Center in Shiraz, Iran. The patient experienced erythroderma and macular rashes shortly after VCZ consumption, leading to generalized exfoliative skin rashes. Concurrent to these skin manifestations, VCZ serum concentration reached the supratherapeutic levels despite the recommended VCZ doses. As a result, VCZ was withheld, and the patient was treated with caspofungin. The lesions were resolved gradually within ۲ weeks, and the patient successfully completed his treatment course with caspofungin. Conclusion: The unique case presented in this study emphasizes the need for a high index of suspicion for VCZ toxicity in any patient with atypical dermatologic manifestations, especially generalized exfoliative skin rashes. Based on this report, VCZ supratherapeutic concentration could be predicted early in the course of treatment. Additional therapeutic dose monitoring should be considered to establish a confirmatory diagnosis. It is required to further investigate the toxic effect of high VCZ concentration on the skin epithelium.

Authors

Ali Amanati

Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Parisa Badiee

Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Mehrzad Lotfi

Medical Imaging Research Center, Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran

Ahmad Monabati

Department of Hematopathology, Molecular Pathology and Cytogenetics, Shiraz University of Medical Sciences, Shiraz, Iran

Mohammad Ali Faghihi

Center for Therapeutic Innovation, Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, USA

Majid Yavarian

Persian Bayan Gene Research and Training Center, Shiraz, Iran

Nazafarin Hatami-Mazinani

Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, ...
  • Williams K, Mansh M, Chin-Hong P, Singer J, Arron ST. ...
  • Vöhringer S, Schrum J, Ott H, Höger PH. Severe phototoxicity ...
  • Sahay P, Asif MI, Maharana PK, Titiyal JS. Periocular contact ...
  • McCarthy KL, Playford EG, Looke DF, Whitby M. Severe photosensitivity ...
  • Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, ...
  • Harris R, Jones H, Artis W. Orally administered ketoconazole: route ...
  • Heykants J, Van Peer A, Van de Velde V, Van ...
  • Cauwenbergh G, Degreef H, Heykants J, Woestenborghs R, Van Rooy ...
  • Jeniel E, Nett DR. Itraconazole. In: Grayson ML, Crowe SM, ...
  • Neely DN. Voriconazole. ۶. Adverse reactions and toxicity. In: Grayson ...
  • Epaulard O, Villier C, Ravaud P, Chosidow O, Blanche S, ...
  • Brown J, Van Manen RP. Voriconazole associated leukoencephalopathy: a review ...
  • Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N. ...
  • Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, ...
  • Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, ...
  • Badiee P, Hashemizadeh Z, Montaseri H. Therapeutic drug monitoring of ...
  • Luong ML, Al-Dabbagh M, Groll AH, Racil Z, Nannya Y, ...
  • Pascual A, Calandra T, Bolay S, Buclin T, Bille J, ...
  • Badiee P, Alborzi A. Detection of Aspergillus species in bone ...
  • Kim SH, Yim DS, Choi SM, Kwon JC, Han S, ...
  • Imhof A, Schaer DJ, Schwarz U, Schanz U. Neurological adverse ...
  • Amanati A, Lotfi M, Manen RV, Faghihi MA, Yavarian M, ...
  • Miyakis S, Van Hal SJ, Ray J, Marriott D. Voriconazole ...
  • Malani AN, Aronoff DM. Voriconazole-induced photosensitivity. Clin Med Res. ۲۰۰۸; ...
  • Denning D, Griffiths C. Muco‐cutaneous retinoid‐effects and facial erythema related ...
  • Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. ...
  • Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, ...
  • Abdel-Haq N, Surapaneni V, Seth D, Pansare M, Asmar BI. ...
  • El Rouby N, Lima JJ, Johnson JA. Proton pump inhibitors: ...
  • Mihăilă RG. Voriconazole and the liver. World J Hepatol. ۲۰۱۵; ...
  • نمایش کامل مراجع